20MED Therapeutics
Year founded
-
Country of origin
Netherlands
HQ country
Netherlands
Total deal value
Average deal value
Company industry
- Medical & Biotech
M&A expertise
- -
Industry expertise
- Healthcare & Pharmaceuticals
20MED Therapeutics B.V. operates as a drug delivery company focused on the development of biodegradable materials for biomedical applications and multifunctional nanosystems for controlled drug and gene delivery.
Latest deals
20Med Therapeutics follow-up Investment Round
22-05-2023
€ 5 - 25 million